Polatuzumab Vedotin
roche
['dlbcl']
new from #ash22 - in a majority of pts with rr- dlbcl who relapse &gt;1 year after 1l treatment, polar-ice demonstrated a high orr with cr without added toxicity due to pola. do you think the longer follow-up will reflect current data? 